ESSA Pharma And 2 Other US Penny Stocks To Watch

Simply Wall St.11-11

As the U.S. stock market reaches record highs amid an election-fueled rally, investors are increasingly exploring diverse opportunities to capitalize on this momentum. Penny stocks, often seen as a ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2482211405?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/5ygIe3mPOH0JnEbDLlu8OA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/1dccd8cfa328dc3b8a3f5e9d2445d8e6","is_english":true,"pubTime":"2024-11-11 08:09","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2482211405","market":"us","top_or_hot":-1,"title":"ESSA Pharma And 2 Other US Penny Stocks To Watch","media":"Simply Wall St.","content":"<div>\n<p>As the U.S. stock market reaches record highs amid an election-fueled rally, investors are increasingly exploring diverse opportunities to capitalize on this momentum. Penny stocks, often seen as a ...</p>\n\n<a href=\"https://finance.yahoo.com/news/essa-pharma-2-other-us-000932233.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ESSA Pharma And 2 Other US Penny Stocks To Watch</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nESSA Pharma And 2 Other US Penny Stocks To Watch\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-11 08:09 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/essa-pharma-2-other-us-000932233.html><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As the U.S. stock market reaches record highs amid an election-fueled rally, investors are increasingly exploring diverse opportunities to capitalize on this momentum. Penny stocks, often seen as a ...</p>\n\n<a href=\"https://finance.yahoo.com/news/essa-pharma-2-other-us-000932233.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4009","symbol_name":"广告","start_time":0,"source_url":"https://finance.yahoo.com/news/essa-pharma-2-other-us-000932233.html","article_id":"2482211405","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/5ygIe3mPOH0JnEbDLlu8OA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/1dccd8cfa328dc3b8a3f5e9d2445d8e6"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2482211405","pubTimestamp":1731283772,"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"As the U.S. stock market reaches record highs amid an election-fueled rally, investors are increasingly exploring diverse opportunities to capitalize on this momentum. Penny stocks, often seen as a relic of past trading days, still hold significant potential for growth and value discovery in today's market landscape. These smaller or newer companies can offer a mix of affordability and upside potential when backed by strong financials, presenting an underappreciated avenue for investors seeking hidden gems in the stock market.Overview: ESSA Pharma Inc. is a clinical-stage pharmaceutical company dedicated to developing small molecule drugs for prostate cancer treatment, with a market cap of $79.86 million.Identiv, Inc., with a market cap of US$92.73 millio","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4009":"广告","BK4195":"互助储蓄与抵押信贷金融服务","BK4526":"热门中概股","RLX":"雾芯科技","BK4551":"寇图资本持仓","BABB":"BAB, Inc.","INVE":"单片机微系统","ASFH":"ASIAFIN HOLDINGS CORP.","BK4211":"区域性银行","BK4209":"餐馆","EPIX":"ESSA Pharma Inc.","BK4563":"昨日强势股","SJ":"思享无限","PVL":"Enduro Royalty Trust","BK4213":"石油与天然气的勘探与生产","ESSA":"萨万通金控","BK4139":"生物科技","BK4075":"烟草","PHX":"潘汉德尔油气"},"translate_title":"ESSA Pharma和另外两只值得关注的美国细价股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BABB":1,"ASFH":1,"RLX":1,"PVL":1,"PHX":1,"ESSA":1,"EPIX":1,"SJ":0.9,"INVE":0.9},"content_text":"As the U.S. stock market reaches record highs amid an election-fueled rally, investors are increasingly exploring diverse opportunities to capitalize on this momentum. Penny stocks, often seen as a relic of past trading days, still hold significant potential for growth and value discovery in today's market landscape. These smaller or newer companies can offer a mix of affordability and upside potential when backed by strong financials, presenting an underappreciated avenue for investors seeking hidden gems in the stock market.\nTop 10 Penny Stocks In The United States\n\n\n\nName\nShare Price\nMarket Cap\nFinancial Health Rating\n\n\nBAB (OTCPK:BABB)\n$0.7656\n$5.56M\n★★★★★★\n\n\nRLX Technology (NYSE:RLX)\n$1.63\n$2.07B\n★★★★★★\n\n\nQuantaSing Group (NasdaqGM:QSG)\n$3.08\n$170.72M\n★★★★★★\n\n\nAsiaFIN Holdings (OTCPK:ASFH)\n$0.97\n$79.11M\n★★★★★★\n\n\nFlexible Solutions International (NYSEAM:FSI)\n$4.10\n$51.05M\n★★★★★★\n\n\nPHX Minerals (NYSE:PHX)\n$3.44\n$128.99M\n★★★★★☆\n\n\nSo-Young International (NasdaqGM:SY)\n$1.25\n$88.26M\n★★★★☆☆\n\n\nPermianville Royalty Trust (NYSE:PVL)\n$1.55\n$51.15M\n★★★★★★\n\n\nPuma Biotechnology (NasdaqGS:PBYI)\n$2.88\n$141.25M\n★★★★★★\n\n\nCBAK Energy Technology (NasdaqCM:CBAT)\n$1.07\n$96.23M\n★★★★★☆\n\n\n\nClick here to see the full list of 740 stocks from our US Penny Stocks screener.\nLet's explore several standout options from the results in the screener.\nESSA Pharma\nSimply Wall St Financial Health Rating: ★★★★★★\nOverview: ESSA Pharma Inc. is a clinical-stage pharmaceutical company dedicated to developing small molecule drugs for prostate cancer treatment, with a market cap of $79.86 million.\nOperations: ESSA Pharma Inc. has not reported any revenue segments as it is currently focused on the clinical development of small molecule drugs for prostate cancer treatment.\nMarket Cap: $79.86M\nESSA Pharma Inc., a pre-revenue company with a market cap of US$79.86 million, recently terminated its Phase 2 clinical trial for masofaniten due to lack of efficacy compared to standard treatment. Despite this setback, the company maintains a strong cash position with short-term assets of US$132.1 million far exceeding liabilities and no debt on its books, providing it with over three years of cash runway at current burn rates. While the stock is highly volatile and unprofitable, analysts forecast significant earnings growth ahead, supported by seasoned management and board experience.\n\nGet an in-depth perspective on ESSA Pharma's performance by reading our balance sheet health report here.\nReview our growth performance report to gain insights into ESSA Pharma's future.\n\n\n\n\n  NasdaqCM:EPIX Debt to Equity History and Analysis as at Nov 2024\n \n\nIdentiv\nSimply Wall St Financial Health Rating: ★★★★★★\nOverview: Identiv, Inc. is a security technology company offering secure identification and physical security solutions globally, with a market cap of $92.73 million.\nOperations: Identiv, Inc. does not report specific revenue segments.\nMarket Cap: $92.73M\nIdentiv, Inc., with a market cap of US$92.73 million, remains unprofitable and has seen losses increase over the past five years. Despite this, it maintains a strong financial position with no debt and short-term assets of US$166 million far exceeding its liabilities. Recent earnings reports show declining sales but a surprising net income swing due to extraordinary items. The company is actively seeking acquisitions as part of its strategic growth plan while also implementing a share repurchase program worth up to US$10 million. Identiv's focus on sustainability through NFC technology could drive future opportunities in digital product passports.\n\nClick here and access our complete financial health analysis report to understand the dynamics of Identiv.\nGain insights into Identiv's future direction by reviewing our growth report.\n\n\n\n\n  NasdaqCM:INVE Debt to Equity History and Analysis as at Nov 2024\n \n\nScienjoy Holding\nSimply Wall St Financial Health Rating: ★★★★★★\nOverview: Scienjoy Holding Corporation operates mobile live streaming platforms in the People’s Republic of China, with a market cap of $41.80 million.\nOperations: The company generates revenue from its Internet Telephone segment, amounting to CN¥1.49 billion.\nMarket Cap: $41.8M\nScienjoy Holding Corporation, with a market cap of $41.80 million, operates in the volatile penny stock space. The company has no debt and boasts short-term assets of CN¥530.7 million surpassing its liabilities, indicating a stable financial footing despite being unprofitable with increasing losses over five years at 27.7% annually. Recent earnings show revenue growth to CN¥374.84 million for Q2 2024 but declining net income compared to the previous year. Scienjoy regained Nasdaq compliance by maintaining a share price above $1 for ten days, reflecting some stability amidst high volatility and ongoing strategic presentations at industry events like LD Micro Main Event XVII.\n\nClick to explore a detailed breakdown of our findings in Scienjoy Holding's financial health report.\nLearn about Scienjoy Holding's historical performance here.\n\n\n\n\n  NasdaqCM:SJ Financial Position Analysis as at Nov 2024\n \n\nTurning Ideas Into Actions\n\nNavigate through the entire inventory of 740  US Penny Stocks here.\nShareholder in one or more of these companies? Ensure you're never caught off-guard by adding your portfolio in Simply Wall St for timely alerts on significant stock developments.\nTake control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor.\n\nSeeking Other Investments?\n\nExplore high-performing small cap companies that haven't yet garnered significant analyst attention.\nJump on the AI train with fast growing tech companies forging a new era of innovation.\nFind companies with promising cash flow potential yet trading below their fair value.\n\n This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.\nCompanies discussed in this article include NasdaqCM:EPIX NasdaqCM:INVE and NasdaqCM:SJ.\nHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2482211405"}